Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial

A quadrivalent high-dose inactivated influenza vaccine (IIV4-HD) is licensed for adults ≥65 y of age based on immunogenicity and efficacy studies. However, IIV4-HD has not been evaluated in adults aged 60–64 y. This study compared immunogenicity and safety of IIV4-HD with a standard-dose quadrivalen...

Descripción completa

Detalles Bibliográficos
Autores principales: Pepin, Stephanie, Nicolas, Jean-François, Szymanski, Henryk, Leroux-Roels, Isabel, Schaum, Thomas, Bonten, Marc, Icardi, Giancarlo, Shrestha, Anju, Tabar, Cynthia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903946/
https://www.ncbi.nlm.nih.gov/pubmed/34714720
http://dx.doi.org/10.1080/21645515.2021.1983387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903946/
https://www.ncbi.nlm.nih.gov/pubmed/34714720
http://dx.doi.org/10.1080/21645515.2021.1983387

Ejemplares similares